Takahashi: Look Out for These Data Integrity Issues
This article was originally published in The Gold Sheet
Executive Summary
Are there more data integrity problems in pharmaceutical manufacturing, or is FDA just getting better at finding them? It’s hard to say, says FDA’s Karen Takahashi, who shares what data integrity issues the agency is seeing during inspections and how it’s spotting them.